Verano Holdings: Analysts Expect $122 Million In EBITDA For Q2

Verano Holdings (CSE: VRNO) announced that they will be reporting their second quarter financials before the market opens on August 10.

Analysts have a consensus C$38.46 12-month price target on the company, via a total of 7 analysts, with 2 analysts having a strong buy rating, and 5 analysts have a buy rating. The street high comes from BTIG with a C$47 price target, and the lowest target comes in at C$19.70.

Six analysts have revenue estimates for the second quarter. The mean between all 6 is C$228.56 million; this number has been revised higher from C$205.51 million at the start of the year. The street high is C$247.37 million while the lowest sits at C$195.80 million.

Four analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 63.55%, with this number being revised slightly downwards from 65% at the start of the year. Street high goes to Beacon Securities with a 71% estimate and the lowest sits at 60%.

Onto EBITDA estimates, there are currently 6 analysts who have second quarter EBITDA estimates. The mean is currently C$122.58 million, with this number being higher than at the start of the year. Street high goes to Roth Capital with a C$248.46 million EBITDA estimate and the lowest being a C$82.10 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Goliath Resources Accelerates Option Agreement On Golddigger While Reducing NSR

Related News

Canaccord: CloudMD’s Third Quarter Results Were “In The Range Of Expectations”

On November 30th, CloudMD Software & Services (TSXV: DOC) reported its third-quarter financial results. CloudMD...

Tuesday, December 1, 2020, 03:41:00 PM

Xebec Adsorption: BMO Cuts Price Target To Just $0.85 After Poor Q2 Margins

Xebec Adsorption (TSX: XBC) yesterday announced its second quarter financial results. The company announced revenues...

Saturday, August 13, 2022, 03:04:00 PM

Trulieve: Canaccord Reiterates $97 Price Target After Virtual Roadshow

Over the last week, Trulieve Cannabis (CSE: TRUL) went on a virtual roadshow mainly focused...

Tuesday, July 6, 2021, 04:04:00 PM

Argonaut Gold: Canaccord Slashes Target To $0.65 Following Dilutive Financing

On July 5, Argonaut Gold (TSX: AR) announced that they closed a C$195.3 million offering...

Thursday, July 7, 2022, 11:39:00 AM

Curaleaf Sees Numerous Analysts Raise Price Targets Following Third Quarter Results

On Tuesday, Curaleaf Holdings (CSE: CURA) reported their third quarter results. The company reported total...

Saturday, November 21, 2020, 01:27:00 PM